Every story as it publishes, newest first.
Apple has built something most companies only dream about: a product ecosystem so sticky that billions of users choose to pay more rather than walk away. Here is why one investor keeps loading up,…
Every quarter, Wall Street fixates on whether hyperscalers will blink and cut their AI budgets, and every quarter the order books tell a completely different story. Here is the basic economic principle that keeps…
One of Wall Street's oldest investing strategies has been quietly beating its own benchmark for years, and there is a dirt-cheap ETF that packages the whole idea into a single ticker most investors have…
Nasdaq-100's biggest names pay next to nothing in dividends, yet one ETF built around them claims a near-10% monthly yield. The math behind that gap reveals a structure that most income investors have never…
Hydrogen and fuel-cell stocks are getting crushed Friday despite bull cases that still look intact, and the reason behind the selloff reveals just how fragile parabolic rallies can be when the market mood shifts.
Beyond covered call funds and preferred stock ETFs, a quieter corner of the income market runs on closed-end fund discounts and floating-rate loan collateral, and the yields range from surprising to almost implausible.
Most people on Original Medicare assume vision coverage is simply off the table, but there is exactly one situation where Medicare will pay for a pair of glasses. Almost everyone who qualifies for it…
Tesla is bleeding market share in investor portfolios to Lucid and Rivian even as it posts record deliveries, and the reason points to a CEO distraction that could get louder before it fades.
Not every ETF that promises weekly income actually delivers it on Friday, and the ones that do arrive at that paycheck through wildly different strategies with very different consequences for your total return.
Most index funds quietly reward whatever the market already loves, pouring more money into winners just because they won. One ETF is built on the opposite logic, and its recent returns suggest the contrarians…
FDVV markets itself as a dividend ETF, but a quarter of its portfolio sits in tech giants that barely yield anything. Whether that tradeoff quietly undermines your income strategy depends on what is actually…
She pulled in six figures before walking away from her job at 63, which should have wiped out her Social Security checks for the rest of the year. A little-known first-year rule buried in…
Federal AI contracts are pouring into enterprise software order books, and two of the sector's most beaten-down stocks are suddenly surging. Whether today's rally marks a genuine turning point or a fleeting squeeze depends…
Eli Lilly just won FDA clearance for an oral GLP-1 that targets over one billion potential patients worldwide, and the stock has barely moved. Here is whether that disconnect signals a buying opportunity or…
Elliott Management's latest 13F filing exposes five positions spanning gold streamers to AI infrastructure, but not all of them still make sense to buy. One has already tripled expectations while another has aged past…
